Food, Global Health 2 min

Discovery of a mechanism that allows Staphylococcus aureus to survive in blood

PRESS RELEASE - Staphylococcus aureus (golden staph) is one of the main causes of bacterial infection in France and throughout the world and is particularly responsible for nosocomial infections. Researchers from INRAE, the CEA and CNRS have discovered how this bacterium can survive in the hostile environment of blood. Staphylococcus aureus detects heme, a molecule that is toxic to bacteria, using a specific bio-sensor that then triggers synthesis of a protective barrier on the bacterium’s surface. This mechanism allows the pathogen to survive and propagate in blood, thereby enabling the infection to spread. Discovering how this sensor works opens up prospects for new antibiotic strategies to control Staphylococcus aureus. These results have been published in the journal mBio.

Published on 06 May 2024

epl betting odds
© INRAE - Régine Talon

Bacterial infections are the second leading cause of death in the world and golden staph, Staphylococcus aureus, is among the deadliest. In 2019, golden staph was deemed to have caused more than one million deaths worldwide and more than 16,000 in France, according to a study published in 2022 in The Lancet. In France, it is one of the main pathogens behind nosocomial (hospital) infections and food poisoning. At the current time, antibiotics are the only effective treatment, but resistant strains have emerged, which leads to the risk of a therapeutic impasse[1]. This is why an INRAE research team, in collaboration with the CEA and CNRS, have been studying Staphylococcus aureus for several years now, in particular to find out how it survives in blood.

Blood: a hostile environment for bacteria

Mammal blood contains red blood cells, which are responsible for transporting oxygen. Those cells contain a large amount of a molecule called heme, which is notably used to bind oxygen. But heme is toxic to bacteria or other cells when it is located outside red blood cells. When pathogenic bacteria like Staphylococcus aureus are in the bloodstream, they cause hemolysis, i.e. the red blood cells burst and free up heme. They can then come into contact with the heme, which is toxic to them.

These researchers discovered that Staphylococcus aureus can detect heme using a specific sensor named HssS, which is found on its membrane. When the sensor detects heme, it triggers a defense mechanism in golden staph, which synthesizes a heme efflux pump that ejects that substance from the bacterium. This creates a protective barrier that allows Staphylococcus aureus to survive in the bloodstream and spread the infection. Laboratory trials have shown that the virulence of those golden staph strains that do not have the HssS sensor and so, are incapable of detecting heme is much weaker.

A way forward for new and innovative antibiotic strategies

Given the problems with antibiotic resistance, these results open new pathways for antibiotic strategies to control Staphylococcus aureus by identifying molecules that inhibit the HssS sensor, thereby decreasing the bacterium's virulence. In addition, since the HssS sensor is specific to pathogenic bacteria, antibiotic strategies that target it will be more focused and, in theory, will not affect bacteria that are beneficial for our bodies, such as those that make up the intestinal microbiota.

Saillant V. et al. HssS activation by membrane heme defines a paradigm for 2-component system signaling in Staphylococcus aureus. mBio, 29 April 2024, DOI:

INRAE Press Office

Scientific contact

Delphine Lechardeur Micalis Institute (INRAE, AgroParisTech, University of Paris-Saclay)



Learn more

Food, Global Health

Food additive E551 could promote coeliac disease

PRESS RELEASE - A recent study has found that food additive E551, also known as silicon dioxide, can reduce oral tolerance to dietary proteins and could foster the development of coeliac disease. Born of a collaboration among researchers at INRAE and McMaster University in Canada, this pioneering work is the first to highlight the potential toxicity of E551, a nanometric ingredient that is added to a wide range of consumer food products. The results were published on 21 February in Environmental Health Perspectives.

19 February 2024

Food, Global Health

When bacteria adapt to new antimicrobials

PRESS RELEASE - The rise of antibiotic resistance jeopardizes current treatments and encourages the search for new targets for antibacterial agents. A new type of antibiotic is being developed to defeat the multi-resistant strains of Staphylococcus aureus. INRA researchers and their colleagues from the Cochin Institute (INSERM, CNRS, and University of Paris) have questioned the rationale behind the choice of this target. Their results, published in Cell Reports (17 December 2019), demonstrate how an infected host can offer bacteria ways to escape1 despite being treated with this new kind of antibiotic.

18 December 2019